To further verify the inhibitory effects of DEPDC1B KD on bladder cancer in vivo, T24 cells were transfected with either shDEPDC1B or shCtrl and used to construct a mouse xenograft model by subcutaneous injection. Here, DEPDC1B is linked to urinary bladder carcinoma.